Skip to main content

Advertisement

Log in

Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Human N-myc downstream-regulated gene 1 (NDRG1) is a metastasis suppressor gene with several potential functions, including cell differentiation, cell cycle regulation and response to hormones, nickel and stress. The purpose of this study was to investigate the immunoexpression of NDRG1 in oral and oropharyngeal squamous cell carcinomas searching for its role in the clinical course of these tumors. We investigated immunohistochemical expression of NDRG1 protein in 412 tissue microarray cores of tumor samples from 103 patients with oral and oropharyngeal squamous cell carcinomas and in 110 paraffin-embedded surgical margin sections. The results showed NDRG1 up-regulation in 101/103 (98.1 %) tumor samples, but no expression in any normal tissue sample. Western blot assays confirmed the immunohistochemical findings, suggesting that lower levels of NDRG1 are associated with a high mortality rate. NDRG1 overexpression was related to long-term specific survival (HR = 0.38; p = 0.009), whereas the presence of lymph-node metastasis showed the opposite association with survival (HR = 2.45; p = 0.013). Our findings reinforce the idea that NDRG1 plays a metastasis suppressor role in oral and oropharyngeal squamous cell carcinomas and may be a useful marker for these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. van Belzen N, Dinjens WN, Diesveld MP et al (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77:85–92

    PubMed  Google Scholar 

  2. Zhao W, Tang R, Huang Y et al (2001) Cloning and expression pattern of the human NDRG3 gene. Biochim Biophys Acta 1519:134–138

    Article  PubMed  CAS  Google Scholar 

  3. Zhou RH, Kokame K, Tsukamoto Y et al (2001) Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73:86–97

    Article  PubMed  CAS  Google Scholar 

  4. Qu X, Zhai Y, Wei H et al (2002) Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol Cell Biochem 229:35–44

    Article  PubMed  CAS  Google Scholar 

  5. Shaw E, McCue LA, Lawrence CE et al (2002) Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. Proteins 47:163–168

    Article  PubMed  CAS  Google Scholar 

  6. Kräuter-Canham R, Bronner R, Evrard J-L et al (1997) A transmitting tissue- and pollen-expressed protein from sunflower with sequence similarity to the human RTP protein. Plant Sci 129:191–202

    Article  Google Scholar 

  7. Qu X, Jia H, Garrity DM et al (2008) Ndrg4 is required for normal myocyte proliferation during early cardiac development in zebrafish. Dev Biol 317:486–496

    Article  PubMed  CAS  Google Scholar 

  8. Guan RJ, Ford HL, Fu Y et al (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749–755

    PubMed  CAS  Google Scholar 

  9. Tepel M, Roerig P, Wolter M et al (2008) Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma. Int J Cancer 123:2080–2086

    Article  PubMed  CAS  Google Scholar 

  10. Kalaydjieva L, Gresham D, Gooding R et al (2000) N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am J Hum Genet 67:47–58

    Article  PubMed  CAS  Google Scholar 

  11. Atiye J, Wolf M, Kaur S et al (2005) Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 42:158–163

    Article  PubMed  CAS  Google Scholar 

  12. Yao J, Weremowicz S, Feng B et al (2006) Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 66:4065–4078

    Article  PubMed  CAS  Google Scholar 

  13. Patmore HS, Ashman JN, Stafford ND et al (2007) Genetic analysis of head and neck squamous cell carcinoma using comparative genomic hybridisation identifies specific aberrations associated with laryngeal origin. Cancer Lett 258:55–62

    Article  PubMed  CAS  Google Scholar 

  14. Angst E, Dawson DW, Nguyen A et al (2010) Epigenetic regulation affects N-myc downstream-regulated gene 1 expression indirectly in pancreatic cancer cells. Pancreas 39(5):675–679

    Article  PubMed  CAS  Google Scholar 

  15. Kovacevic Z, Richardson DR (2006) The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 27:2355–2366

    Article  PubMed  CAS  Google Scholar 

  16. Zhang J, Chen S, Zhang W et al (2008) Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region. Gene 417:5–12

    Article  PubMed  CAS  Google Scholar 

  17. Lachat P, Shaw P, Gebhard S et al (2002) Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 118:399–408

    Article  PubMed  CAS  Google Scholar 

  18. Zhou D, Salnikow K, Costa M (1998) Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res 58:2182–2189

    PubMed  CAS  Google Scholar 

  19. Agarwala KL, Kokame K, Kato H et al (2000) Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. Biochem Biophys Res Commun 272:641–647

    Article  PubMed  CAS  Google Scholar 

  20. Tu LC, Yan X, Hood L et al (2007) Proteomics analysis of the interactome of N-myc downstream regulated gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol Cell Proteomics 6:575–588

    Article  PubMed  CAS  Google Scholar 

  21. Gomez-Casero E, Navarro M, Rodriguez-Puebla ML et al (2001) Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol Carcinog 32:100–109

    Article  PubMed  CAS  Google Scholar 

  22. Kurdistani SK, Arizti P, Reimer CL et al (1998) Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res 58:4439–4444

    PubMed  CAS  Google Scholar 

  23. Dong Z, Arnold RJ, Yang Y et al (2005) Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol Cell Proteomics 4:993–1001

    Article  PubMed  CAS  Google Scholar 

  24. Okuda T, Higashi Y, Kokame K et al (2004) Ndrg1-deficient mice exhibit a progressive demyelinating disorder of peripheral nerves. Mol Cell Biol 24:3949–3956

    Article  PubMed  CAS  Google Scholar 

  25. Kachhap SK, Faith D, Qian DZ et al (2007) The N-myc down regulated gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS One 2(9):e844

    Article  PubMed  Google Scholar 

  26. Chen B, Nelson DM, Sadovsky Y (2006) N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J Biol Chem 281:2764–2772

    Article  PubMed  CAS  Google Scholar 

  27. Said HM, Stein S, Hagemann C et al (2009) Oxygen-dependent regulation of NDRG1 in human glioblastoma cells in vitro and in vivo. Oncol Rep 21:237–246

    PubMed  CAS  Google Scholar 

  28. Bandyopadhyay S, Pai SK, Hirota S et al (2004) Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23:5675–5681

    Article  PubMed  CAS  Google Scholar 

  29. Ando T, Ishiguro H, Kimura M et al (2006) Decreased expression of NDRG1 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma. Dis Esophagus 19:454–458

    Article  PubMed  CAS  Google Scholar 

  30. Cangul H, Salnikow K, Yee H et al (2002) Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol Toxicol 18:87–96

    Article  PubMed  CAS  Google Scholar 

  31. Ummanni R, Junker H, Zimmermann U et al (2008) Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer. Cancer Lett 266:171–185

    Article  PubMed  CAS  Google Scholar 

  32. Bandyopadhyay S, Pai SK, Gross SC et al (2003) The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res 63:1731–1736

    PubMed  CAS  Google Scholar 

  33. Caruso RP, Levinson B, Melamed J et al (2004) Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients. Clin Cancer Res 10:222–227

    Article  PubMed  CAS  Google Scholar 

  34. Chang JT, Wang HM, Chang KW et al (2005) Identification of differentially expressed genes in oral squamous cell carcinoma (OSCC): overexpression of NPM, CDK1 and NDRG1 and underexpression of CHES1. Int J Cancer 114:942–949

    Article  PubMed  CAS  Google Scholar 

  35. Reis EM, Ojopi EP, Alberto FL et al (2005) Large-scale transcriptome analyses reveal new genetic marker candidates of head, neck, and thyroid cancer. Cancer Res 65:1693–1699

    Article  PubMed  Google Scholar 

  36. Chua MS, Sun H, Cheung ST et al (2007) Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Mod Pathol 20:76–83

    Article  PubMed  CAS  Google Scholar 

  37. Song JY, Lee JK, Lee NW (2008) Microarray analysis of normal cervix, carcinoma in situ, and invasive cervical cancer: identification of candidate genes in pathogenesis of invasion in cervical cancer. Int J Gynecol Cancer 18:1051–1059

    Article  PubMed  CAS  Google Scholar 

  38. Akiba J, Murakami Y, Noda M et al (2011) N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G(0)/G(1) phase. Cancer Lett 310(1):25–34

    Article  PubMed  CAS  Google Scholar 

  39. Rose BS, Jeong JH, Nath SK (2011) Population-based study of competing mortality in head and neck cancer. J Clin Oncol 29(26):3503–3509

    Article  PubMed  Google Scholar 

  40. Pentenero M, Gandolfo S, Carrozzo M (2005) Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 27:1080–1091

    Article  PubMed  Google Scholar 

  41. Lallemant B, Evrard A, Chambon G et al (2010) Gene expression profiling in head and neck squamous cell carcinoma: clinical perspectives. Head Neck 32(12):1712–1719

    Article  PubMed  Google Scholar 

  42. Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. John Wiley, Hoboken

    Google Scholar 

  43. Hsu SM, Raine L, Fanger H (1981) The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816–821

    PubMed  CAS  Google Scholar 

  44. Harlow E, Lane D (1988) Antibodies: a laboratory manual. Cold Spring Harbor, New York, p 726

    Google Scholar 

  45. Santos RTMWA, Kamamura CT, Nonogaki S et al (1999) Manual de imuno-histoquímica. Sociedade Brasileira de Patologia, São Paulo

    Google Scholar 

  46. La Rosa S, Uccella S, Erba S et al (2001) Immunohistochemical detection of fibroblast growth factor receptors in normal endocrine cells and related tumors of the digestive system. Appl Immunohistochem Mol Morphol 9:319–328

    Article  PubMed  Google Scholar 

  47. Hsu FD, Nielsen TO, Alkushi A et al (2002) Tissue microarrays are an effective quality assurance tool for diagnostic immunohistochemistry. Mod Pathol 15:1374–1380

    Article  PubMed  Google Scholar 

  48. Bandyopadhyay S, Wang Y, Zhan R et al (2006) The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res 66:11983–11990

    Article  PubMed  CAS  Google Scholar 

  49. Sugiki T, Taketomi Y, Kikuchi-Yanoshita R et al (2004) Association of N-myc downregulated gene 1 with heat-shock cognate protein 70 in mast cells. Biol Pharm Bull 27:628–633

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The GENCAPO group acknowledges the financial support from Fundação de Amparo à Pesquisa do Estado de São Paulo/FAPESP (Grants 04/12054-9), and Associação Beneficente Alzira Denise Hertzog Silva/ABADHS, and the researcher fellowships from Conselho Nacional de Pesquisas (CNPq), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Instituto Israelita de Ensino e Pesquisa Albert Einstein, and The Ludwig Institute for Cancer Research. Fundação de Amparo à Pesquisa do Estado de São Paulo/FAPESP (Grant 04/12054-9).

Conflicts of interest

Authors declare that they have no conflicts of interest.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Adriana Madeira Álvares da Silva.

Appendix

Appendix

The GENCAPO (Head and Neck Genome) Project authors are the following: Cury PM7, de Carvalho MB8, Dias-Neto E3, Figueiredo DLA9, Fukuyama EE5, Góis-Filho JF5, Leopoldino AM15, Mamede RCM9, Michaluart-Junior P6, Moreira-Filho CA17, Moyses RA6, Nóbrega FG4, Nóbrega MP4, Nunes FD13, Ojopi EPB3, Okamoto OK14, Serafini LN10, Severino P1, Silva AMA8,18, Silva Jr WA11, Silveira NJF16, Souza SCOM13, Tajara EH2, Wünsch-Filho V12, Amar A8, Arap SS6, Araújo NSS6, Araújo-Filho V6, Barbieri RB8, Bastos AU8, Brandão LG6, Brandão RM11, Canto AL4, Carmona-Raphe J2, Carvalho Neto PB8, Casemiro AF8, Cerione M5, Cernea CR6, Cicco R5, Chedid H8, Chiappini PBO8, Correia LA8, Costa A12, Costa ACW8, Cunha BR2, Curioni OA8, Dias THG3, Durazzo M6, Ferraz AR6, Figueiredo RO12, Fortes CS12, Franzi SA8, Frizzera APZ7, Gallo J6, Gazito D8, Guimarães PEM6, Gutierres AP8, Henrique T2, Inamine R12, Kaneto CM11, Lehn CN8, López RVM12, Macarenco R4, Magalhães RP6, Magalhães MR8, Martins AE8, Meneses C4, Mercante AMC8, Montenegro FLM6, Pinheiro DG11, Polachini GM2, Porsani AF8, Rapoport A8, Rodini CO13, Rodrigues AN12, Rodrigues-Lisoni FC2, Rodrigues RV2, Rossi L8, Santos ARD11, Santos M8, Settani F5, Silva FAM15, Silva IT11, Silva-Filho GB6, Smith RB6, Souza TB8, Stabenow E6, Takamori JT8, Tavares MR6, Turcano R6, Valentim PJ5, Vidotto A2, Volpi EM6, Xavier FCA13, Yamagushi F5, Bogossian AP4, Cominato ML5, Correa PMS4, Mendes GS5, Paiva R5, Ramos O6, Silva C6, Silva MJ5, Tarlá MVC11, Santos VPP8, Dutra RL8, Alves JL8, Campos JC8, Runga DS8. Affiliations 1Instituto de Ensino e Pesquisa Albert Einstein, São Paulo; 2Departamento de Biologia Molecular, Faculdade de Medicina de São José do Rio Preto; 3Departamento e Instituto de Psiquiatria, Faculdade de Medicina, Universidade de São Paulo (USP), São Paulo; 4Departamento de Biociências e Diagnóstico Bucal, Faculdade de Odontologia, Universidade Estadual Paulista, São José dos Campos, São Paulo, 5Serviço de Cirurgia de Cabeça e Pescoço, Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo; 6Departamento de Cirurgia de Cabeça e Pescoço, Faculdade de Medicina, USP, São Paulo; 7Departamento de Patologia, Faculdade de Medicina de São José do Rio Preto; 8Hospital Heliópolis, São Paulo; 9Serviço de Cirurgia de Cabeça e Pescoço, Faculdade de Medicina de Ribeirão Preto, USP; 10Departamento de Patologia, Faculdade de Medicina de Ribeirão Preto, USP; 11Departamento de Genética, Faculdade de Medicina de Ribeirão Preto, USP; 12Departamento de Epidemiologia, Faculdade de Saúde Pública, USP, São Paulo; 13Departamento de Estomatologia, Faculdade de Odontologia da USP, São Paulo; 14Departamento de Neurologia/Neurocirurgia, UNIFESP, São Paulo; 15Departamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, USP; 16Instituto de Pesquisa e Desenvolvimento, UNIVAP, São José dos Campos; 17Departamento de Pediatria, Faculdade de Medicina, USP, São Paulo, SP, Brazil, 18Universidade Federal do Espírito Santo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

dos Santos, M., da Cunha Mercante, A.M., Nunes, F.D. et al. Prognostic significance of NDRG1 expression in oral and oropharyngeal squamous cell carcinoma. Mol Biol Rep 39, 10157–10165 (2012). https://doi.org/10.1007/s11033-012-1889-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-012-1889-0

Keywords

Navigation